These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 28982978)
1. Defining the interaction of the protease CpaA with its type II secretion chaperone CpaB and its contribution to virulence in Kinsella RL; Lopez J; Palmer LD; Salinas ND; Skaar EP; Tolia NH; Feldman MF J Biol Chem; 2017 Dec; 292(48):19628-19638. PubMed ID: 28982978 [No Abstract] [Full Text] [Related]
3. The Glycoprotease CpaA Secreted by Medically Relevant Acinetobacter Species Targets Multiple Haurat MF; Scott NE; Di Venanzio G; Lopez J; Pluvinage B; Boraston AB; Ferracane MJ; Feldman MF mBio; 2020 Oct; 11(5):. PubMed ID: 33024038 [TBL] [Abstract][Full Text] [Related]
4. Medically Relevant Acinetobacter Species Require a Type II Secretion System and Specific Membrane-Associated Chaperones for the Export of Multiple Substrates and Full Virulence. Harding CM; Kinsella RL; Palmer LD; Skaar EP; Feldman MF PLoS Pathog; 2016 Jan; 12(1):e1005391. PubMed ID: 26764912 [TBL] [Abstract][Full Text] [Related]
5. CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII. Waack U; Warnock M; Yee A; Huttinger Z; Smith S; Kumar A; Deroux A; Ginsburg D; Mobley HLT; Lawrence DA; Sandkvist M mBio; 2018 Dec; 9(6):. PubMed ID: 30563903 [TBL] [Abstract][Full Text] [Related]
6. InvL, an Invasin-Like Adhesin, Is a Type II Secretion System Substrate Required for Acinetobacter baumannii Uropathogenesis. Jackson-Litteken CD; Di Venanzio G; Le NH; Scott NE; Djahanschiri B; Distel JS; Pardue EJ; Ebersberger I; Feldman MF mBio; 2022 Jun; 13(3):e0025822. PubMed ID: 35638734 [TBL] [Abstract][Full Text] [Related]
7. CpaA a novel protease from Acinetobacter baumannii clinical isolates deregulates blood coagulation. Tilley D; Law R; Warren S; Samis JA; Kumar A FEMS Microbiol Lett; 2014 Jul; 356(1):53-61. PubMed ID: 24910020 [TBL] [Abstract][Full Text] [Related]
8. The secretome of Acinetobacter baumannii ATCC 17978 type II secretion system reveals a novel plasmid encoded phospholipase that could be implicated in lung colonization. Elhosseiny NM; El-Tayeb OM; Yassin AS; Lory S; Attia AS Int J Med Microbiol; 2016 Dec; 306(8):633-641. PubMed ID: 27713027 [TBL] [Abstract][Full Text] [Related]
9. Comparative proteomics analyses of Acinetobacter baumannii strains ATCC 17978 and AB5075 reveal the differential role of type II secretion system secretomes in lung colonization and ciprofloxacin resistance. Elhosseiny NM; Elhezawy NB; Attia AS Microb Pathog; 2019 Mar; 128():20-27. PubMed ID: 30578836 [TBL] [Abstract][Full Text] [Related]
10. Genomic and functional analysis of the type VI secretion system in Acinetobacter. Weber BS; Miyata ST; Iwashkiw JA; Mortensen BL; Skaar EP; Pukatzki S; Feldman MF PLoS One; 2013; 8(1):e55142. PubMed ID: 23365692 [TBL] [Abstract][Full Text] [Related]
12. Targeting the Type II Secretion System: Development, Optimization, and Validation of a High-Throughput Screen for the Identification of Small Molecule Inhibitors. Waack U; Johnson TL; Chedid K; Xi C; Simmons LA; Mobley HLT; Sandkvist M Front Cell Infect Microbiol; 2017; 7():380. PubMed ID: 28894700 [TBL] [Abstract][Full Text] [Related]
13. The success of acinetobacter species; genetic, metabolic and virulence attributes. Peleg AY; de Breij A; Adams MD; Cerqueira GM; Mocali S; Galardini M; Nibbering PH; Earl AM; Ward DV; Paterson DL; Seifert H; Dijkshoorn L PLoS One; 2012; 7(10):e46984. PubMed ID: 23144699 [TBL] [Abstract][Full Text] [Related]
14. Frequency of Fallah A; Rezaee MA; Hasani A; Barhaghi MHS; Kafil HS Iran J Basic Med Sci; 2017 Aug; 20(8):849-855. PubMed ID: 29085575 [TBL] [Abstract][Full Text] [Related]
15. Suppressor Mutations in Type II Secretion Mutants of Vibrio cholerae: Inactivation of the VesC Protease. Rule CS; Park YJ; Delarosa JR; Turley S; Hol WGJ; McColm S; Gura C; DiMaio F; Korotkov KV; Sandkvist M mSphere; 2020 Dec; 5(6):. PubMed ID: 33328352 [TBL] [Abstract][Full Text] [Related]
16. Acinetobacter nosocomialis secretes outer membrane vesicles that induce epithelial cell death and host inflammatory responses. Nho JS; Jun SH; Oh MH; Park TI; Choi CW; Kim SI; Choi CH; Lee JC Microb Pathog; 2015 Apr; 81():39-45. PubMed ID: 25778390 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii. Chusri S; Chongsuvivatwong V; Rivera JI; Silpapojakul K; Singkhamanan K; McNeil E; Doi Y Antimicrob Agents Chemother; 2014 Jul; 58(7):4172-9. PubMed ID: 24820079 [TBL] [Abstract][Full Text] [Related]
18. Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond. Weber BS; Harding CM; Feldman MF J Bacteriol; 2015 Dec; 198(6):880-7. PubMed ID: 26712938 [TBL] [Abstract][Full Text] [Related]
19. Outer membrane Protein A plays a role in pathogenesis of Acinetobacter nosocomialis. Kim SW; Oh MH; Jun SH; Jeon H; Kim SI; Kim K; Lee YC; Lee JC Virulence; 2016 May; 7(4):413-26. PubMed ID: 26759990 [TBL] [Abstract][Full Text] [Related]
20. Sun Y; Wang L; Zhang M; Jie J; Guan Q; Fu J; Chu X; Chen D; Li C; Song L; Luo Z-Q mBio; 2024 Jul; 15(7):e0146824. PubMed ID: 38916378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]